Adia Med ADIA
OTC ADIA
$0.13 +0.01 (+8.33%)
At close: Nov 10, 2026 · 4:00 PM EST

Adia Med (ADIA) EBIT Margin (2025 - 2026)

Updated

Adia Nutrition (ADIA) reported EBIT Margin of -86.18% for Q1 2026, up 67.85 percentage points from -154.04% a year earlier.

Analysis

Adia Med (ADIA) EBIT Margin (2025 - 2026) Analysis & Trends

For FY2025, Adia Nutrition posted EBIT Margin of -52.32%, up 2686.69 percentage points from FY2024.

  • By year, EBIT Margin came in at -2739.01% in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Adia Med 12.27 Mn 11.92 Mn 282,580.00 10.68%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.68%
Mar 31, 2026 -86.18%
Jun 30, 2025 -98.68%
Mar 31, 2025 -154.04%
API Access

Adia Med EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=ADIA&period=max&api_key=YOUR_API_KEY